57
Views
7
CrossRef citations to date
0
Altmetric
Tutorial

Oxidized LDL and coronary heart disease

Pages 479-484 | Received 17 Jun 2004, Accepted 25 Jun 2004, Published online: 23 May 2017

References

  • Mertens A, Holvoet P. Oxidized LDL and HDL: antago-nists in atherothrombosis. FASEB J2001; 15(12): 2073–84.
  • Holvoet P, Stassen JM, Van Cleemput J, Caen D, Van-haecke J. Oxidized low density lipoproteins in patients with transplant-associated coronary artery disease. Arterioscler Thromb Vasc Biol 1998; 18(1): 100–7.
  • Holvoet P, Donck J, Landeloos M, Brouwers E, Luijtens K, Arnout J, Lesaffre E, Vanrenterghem Y, Collen D. Correla-tion between oxidized low density lipoproteins and von Willebrand factor in chronic renal failure. Thromb Haemost 1996; 76(5): 663–9.
  • Holvoet P, Vanhaecke J, Janssens S, Van de Werf F, Collen D. Oxidized LDL and malondialdehyde-modified LDL in patients with acute coronary syndromes and stable coronary artery disease. Circulation 1998; 98(15): 1487–94.
  • Holvoet P, Mertens A, Verhamme P, Bogaerts K, Beyens G, Verhaeghe R, Collen D, Muls E, Van de Werf F. Circulat-ing oxidized LDL is a useful marker for identifying patients with coronary artery disease. Arterioscler Thromb Vasc Biol 2001; 21(5): 844–8.
  • Ehara S, Ueda M, Naruko T, Haze K, Itoh A, Otsuka M, Komatsu R, Matsuo T, Itabe H, Takano T, Tsukamoto Y, Yoshiyama M, Takeuchi K, Yoshikawa J, Becker AE. Ele-vated levels of oxidized low density lipoprotein show a pos-itive relationship with the severity of acute coronary syn-dromes. Circulation 2001; 103(15): 1955–60.
  • Toshima S, Hasegawa A, Kurabayashi M, Itabe H, Takano T, Sugano J, Shimamura K, Kimura J, Michishita I, Suzuki T, Nagai R. Circulating oxidized low density lipoprotein levels. A biochemical risk marker for coronary heart disease. Arte-rioscler Thromb Vasc Biol 2000; 20(10): 2243–7.
  • Tsimikas S, Bergmark C, Beyer RW, Patel R, Pattison J, Miller E, Juliano J, Witztum JL. Temporal increases in plasma markers of oxidized low-density lipoprotein strongly reflect the presence of acute coronary syndromes. J Am Coll Cardiol 2003; 41(3): 360–70.
  • Hulthe J, Fagerberg B. Circulating oxidized LDL is associ-ated with increased levels of cell-adhesion molecules in clin-ically healthy 58-year-old men (AIR study). Med Sci Monit 2002; 8(3): CR148-CR152.
  • Hulthe J, Fagerberg B. Circulating oxidized LDL is associ-ated with subclinical atherosclerosis development and inflam-matory cytokines (AIR Study). Arterioscler Thromb Vasc Biol 2002; 22(7): 1162–7.
  • Holvoet P, Harris TB, Tracy RP, Verhamme P, Newman AB, Rubin SM, Simonsick EM, Colbert LH, Kritchevsky SB. Association of high coronary Heart disease risk status with circulating oxidized LDL in the well-functioning elderly: findings from the health, aging, and body Composition Study. Arterioscler Thromb Vasc Biol 2003; 23(8): 1/1/1/1 8.
  • National Institutes of Health. Third Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). NIH Publication 01–3670. 2002. Bethesda, MD: National Institutes of Health.
  • Isomaa B, Almgren P, Tuomi T, Forsen B, Lahti K, Nis-sen M, Taskinen MR, Groop L. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Dia-betes Care 2001; 24(4): 683–9.
  • Trevisan M, Liu J, Bahsas FB, Menotti A. Syndrome X and mortality: a population-based study. Risk Factor and Life Expectancy Research Group. Am J Epidemiol 1998; 148(10): 958–66.
  • Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA 2002; 287(3): 356–9.
  • Holvoet P, Kritchevsky SB, Tracy RP, Mertens A, Rubin SM, Butler J, Goodpaster B, Harris TB. The meta-bolic syndrome, circulating oxidized LDL, and risk of myocardial infarction in well-functioning elderly people in the health, aging, and body composition cohort. Diabetes 2004; 53(4): 1068–73.
  • Lindblad U, Langer RD, Wingard DL, Thomas RG, Barrett-Connor EL. Metabolic syndrome and ischemic heart dis-ease in elderly men and women. Am J Epidemiol 2001; 153(5): 481–9.
  • Shepherd J. Issues surrounding age: vascular disease in the elderly. Curr Opin Lipidol 2001; 12(6): 601–9.
  • Mertens A, Verhamme P, Bielicki JK, Phillips MC, Quarck R, Verreth W, Stengel D, Ninio E, Navab M, Mack-ness B, Mackness M, Holvoet P. Increased low-density lipoprotein oxidation and impaired high-density lipoprotein antioxidant defense are associated with increased macrophage homing and atherosclerosis in dyslipidemic obese mice: LCAT gene transfer decreases atherosclerosis. Circulation 2003; 107(12): 1640–6.
  • Holvoet P, Van Cleemput J, Collen D, Vanhaecke J. Oxi-dized low density lipoprotein is a prognostic marker of trans-plant-associated coronary artery disease. Arterioscler Thromb Vasc Biol 2000; 20(3): 698–702.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.